AzTrials
AzTrials

StrokeMASEANCT01257646

Observation of the Gait Cycle in Patients With Hemiplegia in Order to Improve the Triggering of Functional Electrical Stimulation

A study testing Gait analysis in people with Stroke, run by Centre Hospitalier Universitaire de Nīmes at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The main objective of this study is the estimation and comparison of the dephasing between the switch heel and the inertial placed on the paretic foot compared to the events of the gait cycle determined by a Gaitrite system (beginning and end of the swing phase) in conditions without stimulation. Read more about this study

Who is it for?
Ages 20 to 75 years
Conditions the study is for
Stroke
What is being tested?
Gait analysis
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteFrance
Study dates
May 2011to Jul 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patient has had a first ischemic or hemorragic stroke (supratentorial) within the last 6 months for the "recent stroke" group, or more than a year ago for the "old stroke" group
  • the patient can walk 10 m without human help, with or without a cane, and a deficit of the foot levator requiring the use of technical assistance to remedy this or involving walking problems
  • electrostimulated contraction of the anterior tibialis is possible
  • patient has been informed and has signed the consent form

Who cannot join

  • cognitive disorder making participation in the study difficult
  • fixed plantar flexion, knee extended below 0°
  • patient refuses to sign consent
  • patient is not covered by a social security system
  • patient is under any kind of guardianship

Trial locations and contacts

1 site in 1 country.

France1 site
  • Centre Hospitalier Universitaire de Nîmes

    Nîmes, Gard, 30029

Other trials in France

About this study

The main objective of this study is the estimation and comparison of the dephasing between the switch heel and the inertial placed on the paretic foot compared to the events of the gait cycle determined by a Gaitrite system (beginning and end of the swing phase) in conditions without stimulation.

Conditions
Stroke
Being tested
Gait analysis
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Gait analysisOther

    A Gaitrite system, a goniometer, and EMG are used to record data while the patient walks 10 meters.

Study groups in NCT01257646
Study groupRoleWhat they receive
Recent stroke groupExperimentalThese patients have hemiplegia following a stroke within the last 6 months
Receives: Other: Gait analysis
Old stroke groupActive comparatorThe patients have hemiplegia following a stroke that took place at least a year ago
Receives: Other: Gait analysis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Timing of heel strike (s)

    The goal is to use the data generated by this observational study to predict the timing of the heel strike when a patient walks.

    Measured: 10 seconds

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Dec 2010 (estimated)
  2. Study startMay 2011
  3. Primary completionJul 2013
  4. Study completionJul 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01257646
Sponsor's protocol ID
LOCAL/2009/JF-01
Other IDs
2010-A00534-35
Acronym
MASEA
Status last verified
Mar 2015
First submitted
9 Dec 2010
Last updated
18 Dec 2025
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Gait analysis in people with Stroke, run by Centre Hospitalier Universitaire de Nīmes at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Timing of heel strike (s) (time frame: 10 seconds). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in